Capmatinib-induced interstitial lung disease: A case report

by Kinan El Husseini, Nouha Chaabane, Audrey Mansuet-Lupo, Karen Leroy, Marie-Pierre Revel, Marie Wislez
Published 2020-12-01

Correction to: Pericardial effusion under nivolumab: case-reports and review of the literature

by Anastasia Saade, Audrey Mansuet-Lupo, Jennifer Arrondeau, Constance Thibault, Mariana Mirabel, François Goldwasser, Stéphane Oudard, Laurence Weiss
Published 2019-12-01

Lung Involvement in Chronic Schistosomiasis with Bladder Squamous Cell Carcinoma

by Anastasia Saade, Edith Carton, Audrey Mansuet-Lupo, Romain Jouffroy, Diane Damotte, Hélène Yera, Marie-Pierre Revel, François Goldwasser
Published 2018-12-01

Pre-Disease and Pre-Surgery BMI, Weight Loss and Sarcopenia Impact Survival of Resected Lung Cancer Independently of Tumor Stage

by Philippe Icard, Olivier Schussler, Mauro Loi, Antonio Bobbio, Audrey Mansuet Lupo, Marie Wislez, Antonio Iannelli, Ludovic Fournel, Diane Damotte, Marco Alifano
Published 2020-01-01

Isolated 5′ Signals Are an Atypical Pattern To Be Considered as Positive for ALK Rearrangement: A Brief Report of Three Cases and Review of the Literature

by Alice Guyard, Cécile Charpy, Nathalie Théou-Anton, Anne Cremades, Frédéric Grassin, Anaïs Bourgogne, Karen Leroy, Anaïs Pujals, Christiane Copie-Bergman, Christos Chouaid, Audrey Mansuet-Lupo
Published 2019-05-01

Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer.

by Marco Alifano, Audrey Mansuet-Lupo, Filippo Lococo, Nicolas Roche, Antonio Bobbio, Emelyne Canny, Olivier Schussler, Hervé Dermine, Jean-François Régnard, Barbara Burroni, Jérémy Goc, Jérôme Biton, Hanane Ouakrim, Isabelle Cremer, Marie-Caroline Dieu-Nosjean, Diane Damotte
Published 2014-01-01

Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome

by Véronique M. Braud, Jérôme Biton, Etienne Becht, Samantha Knockaert, Audrey Mansuet-Lupo, Estelle Cosson, Diane Damotte, Marco Alifano, Pierre Validire, Fabienne Anjuère, Isabelle Cremer, Nicolas Girard, Dominique Gossot, Agathe Seguin-Givelet, Marie-Caroline Dieu-Nosjean, Claire Germain
Published 2018-05-01

Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study

by Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, Elizabeth Fabre, Marie Wislez, Marco Alifano, Karen Leroy, Pascaline Boudou-Rouquette, Camille Tlemsani, Nihel Khoudour, Jennifer Arrondeau, Audrey Thomas-Schoemann, Hélène Blons, Audrey Mansuet-Lupo, Diane Damotte, Michel Vidal, François Goldwasser, Jérôme Alexandre, Benoit Blanchet
Published 2020-02-01

The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort

by Diane Damotte, Sarah Warren, Jennifer Arrondeau, Pascaline Boudou-Rouquette, Audrey Mansuet-Lupo, Jérôme Biton, Hanane Ouakrim, Marco Alifano, Claire Gervais, Audrey Bellesoeur, Nora Kramkimel, Camille Tlemsani, Barbara Burroni, Angéline Duche, Franck Letourneur, Han Si, Rebecca Halpin, Todd Creasy, Ronald Herbst, Xing Ren, Pascale Morel, Alessandra Cesano, François Goldwasser, Karen Leroy
Published 2019-11-01

NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas

by Camille Tlemsani, Nicolas Pécuchet, Aurelia Gruber, Ingrid Laurendeau, Claire Danel, Marc Riquet, Françoise Le Pimpec‐Barthes, Elizabeth Fabre, Audrey Mansuet‐Lupo, Diane Damotte, Marco Alifano, Armelle Luscan, Benoit Rousseau, Dominique Vidaud, Jennifer Varin, Beatrice Parfait, Ivan Bieche, Karen Leroy, Pierre Laurent‐Puig, Benoit Terris, Helene Blons, Michel Vidaud, Eric Pasmant
Published 2019-08-01